Market closed
Acelyrin/$SLRN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Acelyrin
Acelyrin Inc is a late-stage clinical biopharmaceutical company. The clinical biopharma segment researches and develops treatments for diseases with pathology related to excess activation of the immune system. It is focused on providing patients with life-changing new treatment options by identifying, acquiring, and accelerating the development and commercialization of transformative medicines.
Ticker
$SLRN
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
83
ISIN
US00445A1007
Website
Acelyrin Metrics
BasicAdvanced
$248M
-
-$2.50
-
-
Price and volume
Market cap
$248M
52-week high
$2.95
52-week low
$2.03
Average daily volume
892K
Financial strength
Current ratio
18.097
Quick ratio
17.076
Long term debt to equity
1.368
Total debt to equity
1.594
Management effectiveness
Return on assets (TTM)
-29.73%
Return on equity (TTM)
-44.54%
Valuation
Price to book
0.54
Price to tangible book (TTM)
0.54
Price to free cash flow (TTM)
-0.8
Growth
Earnings per share change (TTM)
-53.99%
3-year earnings per share growth (CAGR)
-65.50%
Acelyrin News
AllArticlesVideos
Leading Independent Proxy Advisory Firm ISS Recommends ACELYRIN Stockholders Vote “FOR” the Proposed Transaction with Alumis
GlobeNewsWire·4 days ago
ACELYRIN Reiterates Benefits of Value-Maximizing Combination with Alumis
GlobeNewsWire·1 week ago
Alumis and ACELYRIN Announce Amended Merger Agreement
GlobeNewsWire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Acelyrin stock?
Acelyrin (SLRN) has a market cap of $248M as of May 10, 2025.
What is the P/E ratio for Acelyrin stock?
The price to earnings (P/E) ratio for Acelyrin (SLRN) stock is 0 as of May 10, 2025.
Does Acelyrin stock pay dividends?
No, Acelyrin (SLRN) stock does not pay dividends to its shareholders as of May 10, 2025.
When is the next Acelyrin dividend payment date?
Acelyrin (SLRN) stock does not pay dividends to its shareholders.
What is the beta indicator for Acelyrin?
Acelyrin (SLRN) does not currently have a Beta indicator.